ArriVent BioPharma Inc (AVBP)
NASDAQ
Quarter End | Dec 2023 | Mar 2024 |
---|---|---|
USD ($) | USD ($) | |
Cash from Operating Activities | -55.84M | -18.63M |
Cash from Investing Activities | N/A | N/A |
Cash from Financing Activities | 42.86M | 185.63M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Cash from Operating Activities | -43.63M | -55.84M |
Cash from Investing Activities | N/A | N/A |
Cash from Financing Activities | 169.72M | 42.86M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.